EN
Home/Answers/GLP-1s and the pill
ALLAll countries Medicines

Do tirzepatide and semaglutide affect the birth control pill?

What we checked15 sources, each one opened and linked to the sentence it supportsLast checked Nov 9, 2026 · Next review due Nov 9, 2027 · How we write
The short answer

Tirzepatide (Mounjaro, Zepbound) can make the pill less reliable. US, UK, Canadian and Australian labels advise switching to a non-pill method, or adding a barrier such as condoms, for 4 weeks after starting and after each dose increase. EU and Australian semaglutide (Ozempic, Wegovy) labels say it is not expected to weaken the pill.

Why can tirzepatide make the pill less reliable?

Tirzepatide slows how fast the stomach empties, so a pill is absorbed later and less sharply, most of all after the first dose.1

In a study on the US Zepbound label, one 5 mg dose cut the peak level of the pill's oestrogen (ethinyl estradiol) by 59%. Total exposure fell by 20%.1 The progestogen fell by similar amounts, and peaks came 2.5 to 4.5 hours late.1 The Australian label notes that only a single 5 mg dose was studied.7

So the US, Canadian and Australian labels advise a non-oral method, or adding a barrier method. This applies for 4 weeks after starting and for 4 weeks after each dose increase.1,2,7,8,9 The US label says hormonal methods not taken by mouth "should not be affected".1

The windows can run back to back. The US label starts at 2.5 mg and allows a 2.5 mg step after at least 4 weeks.1 Someone stepped up every 4 weeks to 10 mg makes 3 increases, so the windows cover about 16 weeks (our arithmetic).

Do all tirzepatide labels say the same thing?

No. The EU Mounjaro label reports the same study but calls the drop "not considered clinically relevant" and gives no 4-week advice.3

The EU label says no change to the pill is needed. It still recommends contraception for women who could become pregnant.3 The UK label says the same for women with a normal BMI. For women with obesity or overweight, it says reduced effect "cannot be excluded" and gives the 4-week advice.4

The UK regulator, the MHRA, gives the 4-week advice to anyone taking the pill with Mounjaro. It names the coil or implant as methods "not as affected".5 The FSRH, the UK body for contraception doctors, says tirzepatide is the only GLP‑1 medicine found to have a clinically significant effect on the pill.6 India's ESI 2025 obesity guideline also says to switch or add a barrier when tirzepatide is started or increased.15

What about semaglutide, vomiting and diarrhoea?

Semaglutide labels give no pill warning. The EU and Australian Wegovy labels say it is not expected to make the pill less effective.10,11

In the EU label's study, semaglutide left oestrogen exposure unchanged, and the progestogen rose by 20%.10 The US Wegovy label found no clinically significant change in either hormone.12 The FSRH says no barrier method is needed with semaglutide, liraglutide or dulaglutide.6

Sickness is a separate route. The FSRH says vomiting and diarrhoea on any GLP‑1 medicine could stop a pill being absorbed.6 NHS guidance on the combined pill says:13

  • if you vomit less than 3 hours after a pill, take another one straight away
  • if diarrhoea lasts more than 24 hours, keep taking the pill and use condoms until 7 days after it stops

The FSRH adds that persistent vomiting or diarrhoea is a reason to consider a non-oral method.6

Do GLP-1 medicines affect emergency contraception?

The FSRH says there is no direct evidence on GLP‑1 medicines and the emergency pill, and calls the copper coil the most effective emergency method.6

Body weight is a separate issue. The FSRH says a double dose of the levonorgestrel emergency pill should be considered above a BMI of 26, or a weight of 70 kg.6

What do people on GLP-1 medicines report about the pill?

From public patient forums: 7 Reddit threads in r/Zepbound, r/Mounjaro, r/Ozempic, r/mounjaroaustralia and r/WegovyUK, posts from October 2025 to October 2026. Personal reports, not medical evidence.

What people describe

  • Matches the labels Many say they got unclear or conflicting answers about the pill. The labels do differ: the US label advises backup for tirzepatide, and the EU label does not.1,3
  • Not studied Many describe a weight-loss stall after starting or switching hormonal contraception. Many also describe a drop after stopping it, while noting other factors. We found no study of this.
  • Label says otherwise Several mention weighing up stopping contraception to help weight loss. The EU label recommends contraception during tirzepatide treatment, and the MHRA advises it on all GLP‑1 medicines.3,5

Advice people share

  • Matches the label Many advise not relying on the pill alone, but disagree on how long. The US tirzepatide label gives 4 weeks after starting and after each dose increase.1
  • Matches the FSRH Several say the levonorgestrel morning-after pill may work less well at higher weight; replies disagreed on doubling it. The FSRH says a double dose should be considered above a BMI of 26 or 70 kg.6
  • Matches the FSRH Several suggest asking about a copper coil as emergency contraception. The FSRH calls it the most effective method.6

In your country

The tirzepatide study is the same everywhere; what differs is whether the label turns it into 4-week pill advice.

Australia

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.

Label: The answer above applies.

Emergency number: 000

Side effects and risks in Australia

Canada

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.

Label: The answer above applies.

Emergency number: 911

Side effects and risks in Canada

France

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).

Label: The EU Mounjaro label calls the drop in pill hormones "not considered clinically relevant" and says no change to the pill is needed. It gives no 4-week advice, but recommends contraception during treatment.3

Emergency number: 15 or 112

Side effects and risks in France

Germany

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.

Label: The EU Mounjaro label calls the drop in pill hormones "not considered clinically relevant" and says no change to the pill is needed. It gives no 4-week advice, but recommends contraception during treatment.3

Emergency number: 112

Side effects and risks in Germany

India

Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).

Label: We could not find a public Indian label, so this page relies on the US label. India's ESI 2025 obesity guideline gives the same switch-or-barrier advice for tirzepatide.15

Emergency number: 112

Side effects and risks in India

Saudi Arabia

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.

Label: We could not find or open a Saudi label, so this page relies on the US label.

Emergency number: 997 or 911

Side effects and risks in Saudi Arabia

United Arab Emirates

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.

Label: We could not find or open a UAE label, so this page relies on the US label.

Emergency number: 998 for an ambulance, or 999

Side effects and risks in the UAE

United Kingdom

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.

Label: The UK Mounjaro label says no pill change is needed at a normal BMI. It gives the 4-week advice to women with obesity or overweight.4 The MHRA gives the 4-week advice to anyone taking the pill with Mounjaro.5

Emergency number: 999

Side effects and risks in the UK

United States

Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).

Label: The answer above applies.

Emergency number: 911

Side effects and risks in the US

Get help now: call your local emergency number if you vomit blood or something that looks like ground coffee, have green vomit, or have a sudden, severe tummy ache.14 Emergency numbers: 911 in the US and Canada, 999 in the UK, 998 or 999 in the UAE, 000 in Australia, 112 in India and Germany, 15 or 112 in France, 997 or 911 in Saudi Arabia.

Contact your prescriber or a doctor right away if you have severe or long-lasting stomach symptoms, or severe stomach pain that may spread to your back, with or without vomiting.1

Read the full picture

Related questions

Did this answer your question?

Sources

  1. Eli Lilly. Zepbound (tirzepatide) prescribing information, US label, sections 2, 7.2, 8.3, 12.3 and 17. pi.lilly.com (PDF)
  2. Eli Lilly. Mounjaro (tirzepatide) prescribing information, US label, sections 7.2 and 8.3. pi.lilly.com (PDF)
  3. European Medicines Agency. Mounjaro product information, EU label (SmPC), sections 4.5 and 4.6. ema.europa.eu (PDF)
  4. Eli Lilly. Mounjaro KwikPen summary of product characteristics, UK label, section 4.5. medicines.org.uk (emc)
  5. MHRA (UK medicines regulator). GLP-1 medicines for weight loss and diabetes: what you need to know. Updated 5 Feb 2026. gov.uk
  6. FSRH Clinical Effectiveness Unit (now the College of Sexual and Reproductive Healthcare). FSRH statement: GLP-1 agonists and oral contraception. January 2025. Copy hosted by NHS Grampian. communitypharmacy.scot.nhs.uk (PDF)
  7. Eli Lilly Australia. Mounjaro Product Information, Australian label, version A14.0, October 2026, section 4.5. medsinfo.com.au (PDF)
  8. Eli Lilly Canada. Mounjaro product monograph, Canadian label, Reproductive Health and section 9.4. pdf.hres.ca (PDF)
  9. Eli Lilly Canada. Zepbound product monograph, Canadian label, Reproductive Health and section 9.4. pdf.hres.ca (PDF)
  10. European Medicines Agency. Wegovy product information, EU label (SmPC), section 4.5. ema.europa.eu (PDF)
  11. Novo Nordisk Australia. Wegovy Product Information, Australian label, section 4.5. medsinfo.com.au (PDF)
  12. Novo Nordisk. Wegovy (semaglutide) prescribing information, US label, section 12.3. novo-pi.com (PDF)
  13. NHS (UK). What to do if you're sick or have diarrhoea when taking the combined pill. nhs.uk
  14. NHS (UK). Diarrhoea and vomiting: when to call 999 or go to A&E (UK page; use your own country's emergency number). nhs.uk
  15. Madhu SV, et al. ESI clinical practice guidelines for the evaluation and management of obesity in India: an update (2025). Indian J Endocrinol Metab. 2025;29(4):355-365. Full text (PMC)

Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write